PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.77%
Revenue growth above 1.5x 1097.HK's 3.66%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.75%
Gross profit growth under 50% of 1097.HK's 2519.93%. Michael Burry would be concerned about a severe competitive disadvantage.
-32.01%
Negative EBIT growth while 1097.HK is at 48.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-105.70%
Negative operating income growth while 1097.HK is at 48.80%. Joel Greenblatt would press for urgent turnaround measures.
-32.00%
Negative net income growth while 1097.HK stands at 43.73%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.08%
Negative EPS growth while 1097.HK is at 43.72%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-36.92%
Negative diluted EPS growth while 1097.HK is at 43.72%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
3.07%
Share change of 3.07% while 1097.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
8.83%
Diluted share change of 8.83% while 1097.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-11.66%
Negative OCF growth while 1097.HK is at 1780.15%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.97%
Negative FCF growth while 1097.HK is at 202.69%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
594344.75%
Positive 10Y revenue/share CAGR while 1097.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
2498.60%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
381.85%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-11.76%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
278.35%
Positive OCF/share growth while 1097.HK is negative. John Neff might see a comparative advantage in operational cash viability.
302.35%
3Y OCF/share CAGR above 1.5x 1097.HK's 171.72%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
522.96%
Net income/share CAGR above 1.5x 1097.HK's 65.44% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
111.42%
5Y net income/share CAGR 1.25-1.5x 1097.HK's 75.18%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
160.68%
3Y net income/share CAGR above 1.5x 1097.HK's 70.55%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
158.32%
Positive growth while 1097.HK is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-16.81%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-0.02%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.86%
Inventory growth well above 1097.HK's 0.55%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.28%
Positive asset growth while 1097.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.20%
Positive BV/share change while 1097.HK is negative. John Neff sees a clear edge over a competitor losing equity.
16.40%
Debt growth far above 1097.HK's 1.33%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
35.93%
We expand SG&A while 1097.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.